CME Group Inc. Form 8-K Summary
Business Context and Reporting Period
CME Group Inc. filed a Current Report on Form 8-K on July 22, 2026. The filing reports financial results for the quarter ended June 30, 2026, via an attached press release (Exhibit 99.1). The company is incorporated in Delaware and trades on the Nasdaq under the symbol CME.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover report referencing an external press release for these details. It notes that the press release includes both GAAP and non-GAAP financial measures, including revenues, expenses, operating income, net income, and earnings per share.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It states that management believes the non-GAAP measures provide better comparability with prior financial reports, but no specific variance percentages or amounts are listed in the 8-K text itself.
Guidance, Outlook, and Risks
The filing includes standard disclosures regarding the use of non-GAAP financial measures. Management asserts that these measures supplement GAAP results to highlight business trends. The document includes a disclaimer that the information in Item 2.02 and the attached exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. No specific forward-looking guidance, risk factors, or unusual items are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 22, 2026) for specific Q2 2026 revenue and earnings figures.
- Examine the reconciliation of non-GAAP to GAAP financial measures included in the press release.
- Verify the specific year-over-year and quarter-over-quarter changes in trading volumes and net income.
- Check for any updated forward-looking guidance or market commentary in the full press release.